0000899243-20-017109.txt : 20200618
0000899243-20-017109.hdr.sgml : 20200618
20200618173216
ACCESSION NUMBER: 0000899243-20-017109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200616
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stehman-Breen Catherine
CENTRAL INDEX KEY: 0001702233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39319
FILM NUMBER: 20973677
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Generation Bio Co.
CENTRAL INDEX KEY: 0001733294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814301281
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-529-5908
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-16
0
0001733294
Generation Bio Co.
GBIO
0001702233
Stehman-Breen Catherine
C/O GENERATION BIO CO.,
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2020-06-16
4
C
0
5062
A
47523
D
Series C Preferred Stock
2020-06-16
4
C
0
8942
0.00
D
Common Stock
5062
0
D
On June 16, 2020, the Series C Preferred Stock automatically converted into Common Stock on a 1.7663-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
/s/ Jennifer Elliott, Attorney-in-Fact
2020-06-18